Contractor Update: Further products reclassified as special containers from January 2021
Contractor Update: Further products reclassified as special containers from January 2021
January 8, 2021
Following a review of the special container status of certain products, the Department of Health of Social Care (DHSC) has re-determined that a further 14 products for January 2021 now meet the special container criteria as set out in Part II Clause 10B of the Drug Tariff.
| Generic drug name (dm+d descriptor) | Brand and/or Manufacturer | Pack size | Special container |
| Cabozantinib 20mg tablets | Cabometyx (Ipsen Ltd) | 30 | Complete pack |
| Cabozantinib 40mg tablets | Cabometyx (Ipsen Ltd) | 30 | Complete pack |
| Cabozantinib 60mg tablets | Cabometyx (Ipsen Ltd) | 30 | Complete pack |
| Emtricitabine 200mg / Tenofovir 245mg tablets | Mylan | 30 (3 x 10) | Sub-pack of 10 |
| Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution | Kaletra (AbbVie Ltd) | 120ml (2 x 60ml) 300 ml (5 x 60ml) |
Sub-pack of 60ml |
| Pramipexole 0.26mg modified-release tablets | Oprymea (Consilient Health Ltd) | 30 (3 x 10) | Sub-pack of 10 |
| Pramipexole 0.52mg modified-release tablets | Oprymea (Consilient Health Ltd) | 30 (3 x 10) | Sub-pack of 10 |
| Pramipexole 1.05mg modified-release tablets | Oprymea (Consilient Health Ltd) | 30 (3 x 10) | Sub-pack of 10 |
| Pramipexole 1.57mg modified-release tablets | Oprymea (Consilient Health Ltd) | 30 (3 x 10) | Sub-pack of 10 |
| Pramipexole 2.1mg modified-release tablets | Oprymea (Consilient Health Ltd) | 30 (3 x 10) | Sub-pack of 10 |
| Pramipexole 2.62mg modified-release tablets | Oprymea (Consilient Health Ltd) | 30 (3 x 10) | Sub-pack of 10 |
| Pramipexole 3.15mg modified-release tablets | Oprymea (Consilient Health Ltd) | 30 (3 x 10) | Sub-pack of 10 |
| Pheburane 483mg/g granules | Eurocept International bv | 174 gram | Complete pack |
| Regorafenib 40mg tablets | Stivarga (Bayer Plc) | 84 (3 x 28) | Sub-pack of 28 |
To date a total of 92 products have now been reclassified as special containers. For a list of all the monthly changes to the special container status of products please see the following page Notice of changes to special container status of products.
Where a product meets the special container criteria (see Background section) as set out in the Drug Tariff, a special container indicator for the relevant pack size (complete pack or sub-pack) is applied to the respective product entries in dictionary of medicines and devices (dm+d) and in the Drug Tariff, where listed. To assist pharmacy teams and provide full visibility PSNC will provide monthly updates on products that are reclassified as special containers.
If you identify any particular product(s) which are not currently classed as special containers but you believe satisfy the criteria (as set out in Part II CLAUSE 10 B of the Drug Tariff), please notify PSNC’s Dispensing and Supply Team (0203 1220 810 or info@psnc.org.uk) who will investigate and assess if it meets the relevant criteria. Where appropriate, PSNC will make application to the NHSBSA and DHSC seeking for the special container status of the product(s) to be re-determined.
Posted in: Dispensing & Supply, PSNC News
